Experts: Sites Should Look for Signs of Falsified Data

When an investigator is found to have falsified patient data, it can affect all research conducted at that clinical site, experts say. A site must inform an institutional review board reviewing other studies at the site of the incident, Melanie Griswold, director of research for South Carolina Clinical Research Center, said. A site also must notify sponsors of other studies it is conducting, she added. However, the site monitor, who usually visits sites every six weeks to ensure compliance, has the primary responsibility to report suspicious data, Linda Sall, site manager of Artesia, Calif.-based Sall Research Medical Center, said.
Clinical Trials Advisor